EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische Studie

Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―

Hiroaki Kitaoka, Masaki Ieda, Mio Ebato, Ken Kozuma, Morimasa Takayama, Kaoru Tanno, Nobuyuki Komiyama, Yasushi Sakata, Yuichiro Maekawa, Yuichiro Minami, Akiyoshi Ogimoto, Tomofumi Takaya und 11 weitere

Circulation Journal · 25.12.2024 · 89 (1) · 130-138

DOI: 10.1253/circj.cj-24-0501 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Circulation Journal, erschienen am 25.12.2024. Verfasst von Hiroaki Kitaoka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University. Hauptthemen laut MEDLINE: Benzylamines, Cardiomyopathy, Hypertrophic, Uracil. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Bristol Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzylaminesCardiomyopathy, HypertrophicUracilAdultAgedFemaleHumansMaleMiddle AgedEast Asian PeopleJapanNatriuretic Peptide, BrainStroke VolumeTreatment OutcomeVentricular Function, Left

Stichwörter der Autor:innen

EfficacyHypertrophic cardiomyopathyMavacamtenSafety

Substanzen

BenzylaminesMYK-461Natriuretic Peptide, BrainUracil

Autor:innen und Institutionen

  • Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University.
  • Department of Cardiology, Keio University School of Medicine.
  • Department of Cardiovascular Medicine, Showa University Fujigaoka Hospital.
  • Department of Cardiology, Teikyo University Hospital.
  • Department of Cardiology, Sakakibara Heart Institute.
  • Division of Cardiology, Cardiovascular Center, Showa University Koto Toyosu Hospital.

Förderung

  • Bristol Myers Squibb

Zitieren

APA

Kitaoka, H., Ieda, M., Ebato, M., Kozuma, K., Takayama, M., Tanno, K., Komiyama, N., Sakata, Y., Maekawa, Y., Minami, Y., Ogimoto, A., Takaya, T., Yasuda, S., Amiya, E., Furukawa, Y., Watanabe, T., Hiraya, D., Miyagoshi, H., Kinoshita, G., …, & Izumi, C. (2024). Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―. Circulation Journal, 89(1), 130-138. https://doi.org/10.1253/circj.cj-24-0501

Vancouver

Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, et al. Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―. Circulation Journal. 2024;89(1):130-138. doi:10.1253/circj.cj-24-0501

BibTeX
@article{Kitaoka2024,
  author = {Kitaoka, Hiroaki and Ieda, Masaki and Ebato, Mio and Kozuma, Ken and Takayama, Morimasa and Tanno, Kaoru and Komiyama, Nobuyuki and Sakata, Yasushi and Maekawa, Yuichiro and Minami, Yuichiro and Ogimoto, Akiyoshi and Takaya, Tomofumi and Yasuda, Satoshi and Amiya, Eisuke and Furukawa, Yutaka and Watanabe, Tetsuya and Hiraya, Daigo and Miyagoshi, Hidetaka and Kinoshita, Gen and Reedy, Alison and Hegde, Sheila M and Florea, Victoria and Izumi, Chisato},
  title = {Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―},
  journal = {Circulation Journal},
  year = {2024},
  volume = {89},
  number = {1},
  pages = {130--138},
  doi = {10.1253/circj.cj-24-0501}
}
Kostenlos starten →